An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Eisai Inc. ( Eisai Co., Ltd. )
ClinicalTrials.gov Identifier:
NCT00280397
First received: January 20, 2006
Last updated: May 10, 2013
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
No publications provided by Eisai Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):